Mazkeret Batya, Israel

Eduardo Zawoznik

This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Neuroderm, Ltd.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eduardo Zawoznik. Retrieved from https://idiyas.com/inventor/eduardo-zawoznik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Eduardo Zawoznik

Introduction

Eduardo Zawoznik is a notable inventor based in Mazkeret Batya, Israel. He has made significant contributions to the field of transdermal delivery systems. His work focuses on developing compositions that enhance the effectiveness of therapeutic agents.

Latest Patents

Zawoznik holds a patent for "Compositions for transdermal delivery of active agents." This patent discloses compositions that are useful in effecting the transdermal delivery of therapeutic agents. The transdermal compositions may include a fatty alcohol, such as octanol, a terpene like limonene, and an active agent comprising an amine moiety. He has 1 patent to his name.

Career Highlights

Eduardo Zawoznik is currently associated with Neuroderm, Ltd., where he continues to innovate in the field of drug delivery systems. His work at Neuroderm has positioned him as a key player in the development of advanced therapeutic solutions.

Collaborations

Some of his notable coworkers include Oron Yacoby-Zeevi and Mara Nemas. Their collaborative efforts contribute to the innovative environment at Neuroderm.

Conclusion

Eduardo Zawoznik's contributions to transdermal delivery systems highlight his role as an influential inventor in the pharmaceutical industry. His innovative work continues to pave the way for advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…